Sylvie Rusakiewicz
Papers
2
Total Citations
5
H-Index
2
About
Sylvie Rusakiewicz is a leading researcher at the intersection of computational pathology and cancer immunology, with her most impactful work centered on multi-modal image analysis for large-scale cancer tissue studies. As a key contributor to the IMMUcan consortium, she has pioneered methods for integrating diverse imaging modalities—including multiplexed immunofluorescence and histology—to characterize the tumor microenvironment (TME) at unprecedented scale. Her major contributions include developing robust analytical pipelines capable of processing imaging data from thousands of patients, enabling the systematic immunoprofiling of large adaptive cancer cohorts. This work has been instrumental in linking TME architecture to patient prognosis, offering new insights into how immune cell spatial organization influences clinical outcomes. Her 2025 publications, already garnering citations, highlight the growing demand for scalable, multi-modal approaches in cancer research. Rusakiewicz’s achievements are particularly notable for addressing a critical bottleneck in the field: the transition from small-scale, proof-of-concept studies to population-level analyses that can drive biomarker discovery and therapeutic stratification. Her research is essential reading for anyone interested in computational pathology, spatial biology, or the future of data-driven cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1
- 2